APELLIS PHARMACEUTICALS INC. - COMMON STOCK
27.98
14-November-24 09:48:07
15 minutes delayed
Stocks
-0.27
-0.96%
Today's range
27.81 - 28.49
ISIN
N/A
Source
NASDAQ
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Dec 2023 15:05:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals to Host a Fireside Chat at the 6th Annual Evercore ISI HealthCONx Conference
21 Nov 2023 06:00:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Nov 2023 15:05:00 By Nasdaq GlobeNewswire
-
04 Nov 2023 12:37:55 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Reports Third Quarter 2023 Financial Results
01 Nov 2023 06:05:00 By Nasdaq GlobeNewswire
-
25 Oct 2023 06:00:00 By Nasdaq GlobeNewswire
-
20 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
17 Oct 2023 06:00:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Oct 2023 15:05:00 By Nasdaq GlobeNewswire
-
05 Oct 2023 06:00:00 By Nasdaq GlobeNewswire
-
02 Oct 2023 06:00:00 By Nasdaq GlobeNewswire
-
25 Sep 2023 06:30:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 Sep 2023 15:05:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
30 Aug 2023 06:00:00 By Nasdaq GlobeNewswire
-
29 Aug 2023 05:58:00 By Nasdaq GlobeNewswire
-
22 Aug 2023 15:43:29 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 Aug 2023 15:05:00 By Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Reports Second Quarter 2023 Financial Results
31 Jul 2023 06:00:00 By Nasdaq GlobeNewswire
-
30 Jul 2023 12:00:40 By Nasdaq GlobeNewswire
-
29 Jul 2023 13:52:12 By Nasdaq GlobeNewswire